181 related articles for article (PubMed ID: 14978273)
1. Cellular protein is the source of cross-priming antigen in vivo.
Shen L; Rock KL
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3035-40. PubMed ID: 14978273
[TBL] [Abstract][Full Text] [Related]
2. Peptides chaperoned by heat-shock proteins are a necessary and sufficient source of antigen in the cross-priming of CD8+ T cells.
Binder RJ; Srivastava PK
Nat Immunol; 2005 Jun; 6(6):593-9. PubMed ID: 15864309
[TBL] [Abstract][Full Text] [Related]
3. Cross-presentation: underlying mechanisms and role in immune surveillance.
Rock KL; Shen L
Immunol Rev; 2005 Oct; 207():166-83. PubMed ID: 16181335
[TBL] [Abstract][Full Text] [Related]
4. Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells.
Bertholet S; Debrabant A; Afrin F; Caler E; Mendez S; Tabbara KS; Belkaid Y; Sacks DL
Infect Immun; 2005 Oct; 73(10):6620-8. PubMed ID: 16177338
[TBL] [Abstract][Full Text] [Related]
5. Essential role of endogenous heat shock protein 90 of dendritic cells in antigen cross-presentation.
Ichiyanagi T; Imai T; Kajiwara C; Mizukami S; Nakai A; Nakayama T; Udono H
J Immunol; 2010 Sep; 185(5):2693-700. PubMed ID: 20668218
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 3 promotes cross-priming to virus-infected cells.
Schulz O; Diebold SS; Chen M; Näslund TI; Nolte MA; Alexopoulou L; Azuma YT; Flavell RA; Liljeström P; Reis e Sousa C
Nature; 2005 Feb; 433(7028):887-92. PubMed ID: 15711573
[TBL] [Abstract][Full Text] [Related]
7. Antigen bias in T cell cross-priming.
Wolkers MC; Brouwenstijn N; Bakker AH; Toebes M; Schumacher TN
Science; 2004 May; 304(5675):1314-7. PubMed ID: 15166378
[TBL] [Abstract][Full Text] [Related]
8. Heat shock protein-antigen fusions lose their enhanced immunostimulatory capacity after endotoxin depletion.
Marincek BC; Kühnle MC; Srokowski C; Schild H; Hämmerling G; Momburg F
Mol Immunol; 2008 Nov; 46(1):181-91. PubMed ID: 18804283
[TBL] [Abstract][Full Text] [Related]
9. Immortalized dendritic cell line with efficient cross-priming ability established from transgenic mice harboring the temperature-sensitive SV40 large T-antigen gene.
Ebihara S; Endo S; Ito K; Ito Y; Akiyama K; Obinata M; Takai T
J Biochem; 2004 Sep; 136(3):321-8. PubMed ID: 15598888
[TBL] [Abstract][Full Text] [Related]
10. CD8+ T cell cross-priming via transfer of proteasome substrates.
Norbury CC; Basta S; Donohue KB; Tscharke DC; Princiotta MF; Berglund P; Gibbs J; Bennink JR; Yewdell JW
Science; 2004 May; 304(5675):1318-21. PubMed ID: 15166379
[TBL] [Abstract][Full Text] [Related]
11. Priming of T cells by exogenous antigen cross-presented on MHC class I molecules.
Shen L; Rock KL
Curr Opin Immunol; 2006 Feb; 18(1):85-91. PubMed ID: 16326087
[TBL] [Abstract][Full Text] [Related]
12. Post-apoptotic tumors are more palatable to dendritic cells and enhance their antigen cross-presentation activity.
Brusa D; Garetto S; Chiorino G; Scatolini M; Migliore E; Camussi G; Matera L
Vaccine; 2008 Nov; 26(50):6422-32. PubMed ID: 18848858
[TBL] [Abstract][Full Text] [Related]
13. Differential capacity of chaperone-rich lysates in cross-presenting human endogenous and exogenous melanoma differentiation antigens.
Bleifuss E; Bendz H; Sirch B; Thompson S; Brandl A; Milani V; Graner MW; Drexler I; Kuppner M; Katsanis E; Noessner E; Issels RD
Int J Hyperthermia; 2008 Dec; 24(8):623-37. PubMed ID: 18608582
[TBL] [Abstract][Full Text] [Related]
14. Induction of cytotoxic T lymphocyte activity by immunization with recombinant Semliki Forest virus: indications for cross-priming.
Huckriede A; Bungener L; Holtrop M; de Vries J; Waarts BL; Daemen T; Wilschut J
Vaccine; 2004 Mar; 22(9-10):1104-13. PubMed ID: 15003637
[TBL] [Abstract][Full Text] [Related]
15. Targeting to static endosome is required for efficient cross-presentation of endoplasmic reticulum-resident oxygen-regulated protein 150-peptide complexes.
Kutomi G; Tamura Y; Okuya K; Yamamoto T; Hirohashi Y; Kamiguchi K; Oura J; Saito K; Torigoe T; Ogawa S; Hirata K; Sato N
J Immunol; 2009 Nov; 183(9):5861-9. PubMed ID: 19812200
[TBL] [Abstract][Full Text] [Related]
16. Cross-presentation of a human tumor antigen delivered to dendritic cells by HSV VP22-mediated protein translocation.
Chhabra A; Mehrotra S; Chakraborty NG; Mukherji B; Dorsky DI
Eur J Immunol; 2004 Oct; 34(10):2824-33. PubMed ID: 15368298
[TBL] [Abstract][Full Text] [Related]
17. The cross-priming pathway: a portrait of an intricate immune system.
Basta S; Alatery A
Scand J Immunol; 2007 Apr; 65(4):311-9. PubMed ID: 17386021
[TBL] [Abstract][Full Text] [Related]
18. Efficiency of peptide presentation by dendritic cells compared with other cell types: implications for cross-priming.
Zehn D; Cohen CJ; Reiter Y; Walden P
Int Immunol; 2006 Dec; 18(12):1647-54. PubMed ID: 17035346
[TBL] [Abstract][Full Text] [Related]
19. Direct presentation of a melanocyte-associated antigen in peripheral lymph nodes induces cytotoxic CD8+ T cells.
Schuler P; Contassot E; Irla M; Hugues S; Preynat-Seauve O; Beermann F; Donda A; French LE; Huard B
Cancer Res; 2008 Oct; 68(20):8410-8. PubMed ID: 18922914
[TBL] [Abstract][Full Text] [Related]
20. Increased antigen cross-presentation but impaired cross-priming after activation of peroxisome proliferator-activated receptor gamma is mediated by up-regulation of B7H1.
Klotz L; Hucke S; Thimm D; Classen S; Gaarz A; Schultze J; Edenhofer F; Kurts C; Klockgether T; Limmer A; Knolle P; Burgdorf S
J Immunol; 2009 Jul; 183(1):129-36. PubMed ID: 19535643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
